Bleeding clinical trials

Explore recruiting bleeding clinical trials.

Recruiting bleeding studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bleeding trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Chronic anticoagulation in end-stage renal disease patients: pharmacocinetics and pharmacodynamic of a reduced dose regimen of rivaroxaban (CARD-AXA)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Single vs. dual antiplatelet therapy in elderly or HBR patients undergoing percutaneous intervention with drug-coated balloons (PICCOLETO IV-EPIC 38)

Italy, Spain, Luxembourg, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Tranexamic Acid for reduction of intra- and postoperative TRansfusion Requirements in elective Abdominal surgery: randomized controlled trial (TATRA)

Germany

Therapeutic use (Phase IV) EU CTIS Study details

ARGX-113-2409: A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo- Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants from 12 Years to Less Than 18 Years of Age with Chronic ITP

Lithuania, Romania, Hungary, France, Italy, Spain +2 more

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized, double-blind, multi-center, placebo-controlled, parallel-group phase 3 study to compare the efficacy, acceptability, and safety of Tranexamic Acid Oral Solution 5% with placebo in the prevention of clinically relevant bleeding events in subjects treated with direct oral anticoagulants or vitamin K antagonists and undergoing a single or multiple tooth extraction

Spain, Hungary, Croatia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Low INR to Minimize bleeding with mechanical valves Trial (LIMIT)

Spain, Belgium, Denmark, Germany, Italy, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Bleeding trials by city

Bleeding in Toronto Bleeding in Vancouver Bleeding in Montreal Bleeding in Calgary Bleeding in Edmonton Bleeding in Ottawa Bleeding in Winnipeg Bleeding in Quebec City Bleeding in Hamilton Bleeding in Kitchener Bleeding in London Bleeding in Halifax Bleeding in New York Bleeding in Los Angeles Bleeding in Chicago Bleeding in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease